Skip to main content
Sa1851 LOW PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE.
Mo1901 CHILDREN WITH INFLAMMATORY BOWEL DISEASE EXPERIENCE HIGH RATES OF TRAUMA SECONDARY TO MEDICAL TREATMENT.
Mo1894 APPROACH TO TRANSGENDER AND GENDER NON-CONFORMING (TGNC) YOUTH IN A PEDIATRIC INFLAMMATORY BOWEL DISEASE CENTER.
Tu1710 – Ustekinumab to Treat Pediatric Patients with Crohn's Disease: A Single Center Experience.
Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
P019 DEPRESSION PREDICTS LENGTH OF HOSPITAL STAY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE.
Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.
Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.
Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.